CPT1A and fatty liver disease: Methyl FA could inhibit lipid synthesis through AMPK and FoxO1 signal pathways while promoting lipid oxidation via the SIRT1/PPAR-α/CPT-1α axis, ultimately attenuating ethanol-induced hepatic steatosis [36].